Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Infection, inflammation, height, and longevity
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation – A pilot study
2015
Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration.
2005
Vascular Actions of Estrogens: Functional Implications
2008
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Mechanisms of Thrombus Formation
2008 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Platelet adhesion in atrial fibrillation
2007
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
D‐Dimer for venous thromboembolism diagnosis: 20 years later
2008
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation
2002
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation
2007
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
2007
Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents
1994
Glutamate uptake
2001 Standout
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation
2005
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
Common infections and the risk of stroke
2010
Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation
2000
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation
2007
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia
2003
Does atrial fibrillation confer a hypercoagulable state?
1995
Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials
1994
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Adrenal steroids and plasticity of hippocampal neurons: Toward an understanding of underlying cellular and molecular mechanisms
1993
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone
2009
Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
1997 Standout
Na+ channels as targets for neuroprotective drugs
1995
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes
2006
Neuronal Apoptosis: Current Understanding of Molecular Mechanisms and Potential Role in Ischemic Brain Injury
1995
Use-Dependent Exaggeration of Brain Injury: Is Glutamate Involved?
1999
Aconitum in Traditional Chinese Medicine—A valuable drug or an unpredictable risk?
2009 Standout
Latent Palmprint Matching
2008
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Effects of Aspirin and Clopidogrel versus Oral Anticoagulation on Platelet Function and on Coagulation in Patients with Nonvalvular Atrial Fibrillation (CLAFIB)
2002
Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade
1995
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
2002
Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice
2003
D-dimer level influences thromboembolic events in patients with atrial fibrillation
2005
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
2000 Standout
Relation of Left Atrial Spontaneous Echo Contrast With Prethrombotic State in Atrial Fibrillation Associated With Systemic Hypertension, Idiopathic Dilated Cardiomyopathy, or No Identifiable Cause (Lone) 11This study was supported in part by Grant DOH84-HR-206 from the National Health Research Institute, Taipei, Taiwan, Republic of China.
1998
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
2010
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
1997 Standout
Human Identification Using Finger Images
2011 Standout
17β-Estradiol inhibits cytokine induction of the human E-selectin promoter
2002
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Transgender Medicare Beneficiaries and Chronic Conditions: Exploring Fee-for-Service Claims Data
2017 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
The Complex Role of Estrogens in Inflammation
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
[Guidelines for the management of patients with atrial fibrillation. Executive summary].
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Endothelial Dysfunction
2003 Standout
Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations
2006
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
1995
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
1991 Standout
Principles of Experience-Dependent Neural Plasticity: Implications for Rehabilitation After Brain Damage
2008 Standout
Testosterone Treatment and Mortality in Men with Low Testosterone Levels
2012 Standout
Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women
2002
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation
2004
Spatial training in a complex environment and isolation alter the spine distribution differently in rat CA1 pyramidal cells
1997 StandoutNobel
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation
2005
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm
1995
Guidelines for the Primary Prevention of Stroke
2014 Standout
STRESS AND HIPPOCAMPAL PLASTICITY
1999 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.
1997
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol
2016
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
1993
Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation
2002
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
2003
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
2016
Thromboembolic complications in atrial fibrillation.
1990
Seizures and Epilepsy After Ischemic Stroke
2004
New Thrombotic Events in Ischemic Stroke Patients with Elevated Factor VIII
2014
Effects of Anticoagulation Intensity on Hemostatic Markers in Patients With Non-Valvular Atrial Fibrillation
2003
Inflammation in Cardiovascular Disease
2002
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review
2013
Statin Attenuates Increase in C-Reactive Protein During Estrogen Replacement Therapy in Postmenopausal Women
2002
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cerebral Blood Flow before and after Cardioversion of Atrial Fibrillation
1989
Ischemic Cell Death in Brain Neurons
1999 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
The Metabolic Syndrome
2008 Standout
Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
1999
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
1991
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
1997
Increased Expression of P-Selectin on Platelets Is a Risk Factor for Silent Cerebral Infarction in Patients With Atrial Fibrillation
1998
Plasmin-α2-antiplasmin Complex in Patients with Atrial Fibrillation
1999
Relationship between Flow Dynamics in the Left Atrium and Hemostatic Abnormalities in Patients with Nonvalvular Atrial Fibrillation.
1998
Atrial Fibrillation Activates Platelets and Coagulation in a Time-Dependent Manner: A Study in Patients With Paroxysmal Atrial Fibrillation
1997
Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation
1996
Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study.
1993
Works of Anders Hamsten being referenced
Correlation between plasma levels of growth factors and von Willebrand factor
1989
APC resistance during the normal menstrual cycle
2007
Antibodies to phospholipids in thrombotic disease
1989
Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.
1990
Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women
2001